rdfs: label
en
fr
pt
pt-br
"Doença Huntington-like 2"@pt
"Doença Huntington-like 2"@pt-br
"Huntington disease-like 2"@en
"maladie de Huntington-like 2"@fr
skos: altLabel
"HDL2"@en
"HUNTINGTON DISEASE-LIKE 2; HDL2"@en
"Huntington Disease-Like type 2"@en
"Huntington's disease-like 2"@en
schema: description
"Huntington disease-like 2 (HDL2) is a severe neurodegenerative disorder considered part of the neuroacanthocytosis syndromes (see this term) characterized by a triad of movement, psychiatric, and cognitive abnormalities"@en
schema: dateModified
"2026-10-24T00:52:04+00:00"^^xsd:dateTime
schema: version
2560169585
wikibase: identifiers
9
wikibase: sitelinks
0
wikibase: statements
36
p: P11430
wd: statement/Q30990046-80f92e30-4759-ad55-7f06-0bab72ffada4
p: P1193
wd: statement/Q30990046-6F0197B8-F78C-4BBB-8A61-03078116F410
p: P14914
wd: statement/Q30990046-E3C32FB7-198B-47F1-BF82-0D465F85B963
p: P1550
wd: statement/Q30990046-1CD1487F-E72A-43CB-ACAD-02D50145AE2D
p: P1995
wd: statement/Q30990046-AB64427E-87EE-434E-AB54-F7704413116D
p: P2293
wd: statement/Q30990046-ED3D19F8-73F5-4600-BE90-29D99679EA1B
p: P279
wd: statement/Q30990046-329fc5c6-4bea-647d-8fef-e240ff23f63c
wd: statement/Q30990046-98D32DCC-EE66-4E0C-949D-2F440496F8B4
wd: statement/Q30990046-AC89B5ED-F1D8-4F30-AD91-8BA4CD9A43F7
p: P2841
wd: statement/Q30990046-83D50DE4-2FA6-4EC4-ADB4-96C3AE43F712
p: P2888
wd: statement/Q30990046-625AF25E-9C62-431A-90CE-07062020A1A9
wd: statement/Q30990046-6381A4A1-12D3-4AE6-A52C-3B5DB9119BC6
p: P2892
wd: statement/Q30990046-2A3C5BF7-F3C4-4682-965B-7E08DABA816C
p: P31
wd: statement/Q30990046-831282D4-F245-4ADD-99D9-8F368C9632B8
wd: statement/Q30990046-E9E03EFC-E565-41FC-83F7-E877A9BCB3B4
p: P4229
wd: statement/Q30990046-BEC8E5DB-CA1D-415F-B677-3B07540182A8
p: P486
wd: statement/Q30990046-7fd6788e-40f6-4260-b944-89bc7e24669b
p: P492
wd: statement/Q30990046-D8D00608-6FBE-49CF-82A4-701F877C2206
p: P5008
wd: statement/Q30990046-425B0B3D-83D7-42AA-96CF-C5A4BE17FB6F
p: P5270
wd: statement/Q30990046-796A3AD9-67B4-4D0A-8E3D-8DB37EC324FF
p: P6532
wd: statement/Q30990046-081409F6-13FF-46F2-B8E8-051A89062A5F
wd: statement/Q30990046-121A98A8-50E8-4435-886F-39673D7BD90F
wd: statement/Q30990046-28BE7081-5BDB-4EC9-B771-85B8C2211835
wd: statement/Q30990046-3DFDEAC1-0B64-4DB5-9C2E-AC446D715FDE
wd: statement/Q30990046-57317327-39F3-4B8A-BF81-F7F85210BB09
wd: statement/Q30990046-66CC983D-790F-4C1B-A1F5-19D7DDFB0D1F
wd: statement/Q30990046-892EA1A2-C123-4A1B-8A36-33619BFC44CB
wd: statement/Q30990046-90D1A964-08BB-4C06-A1DA-D4F6B8DA9EA7
wd: statement/Q30990046-95256647-68AA-4C98-A2C3-902B035EE63F
wd: statement/Q30990046-CAFD5FC8-E5A8-4348-8A6C-F68766611585
wd: statement/Q30990046-D073A61D-278F-4877-AEB0-F6AEFD5F505A
wd: statement/Q30990046-D9A9EC63-B0FC-4A2C-96D2-2DFA89807E12
wd: statement/Q30990046-E56F5F5F-4400-4562-889C-311BE8ECF22E
wd: statement/Q30990046-F0564784-0C14-4A84-B6D7-7E4F68ABFB7B
wd: statement/Q30990046-F7B6B7F2-15D7-42F5-BA07-BB2F335196C0
p: P699
wd: statement/Q30990046-2DD51635-2246-48AA-ADBD-8B934E2B4C1B
p: direct-normalized/P486
<http://id.nlm.nih.gov/mesh/C564708>
p: direct-normalized/P5270
<http://purl.obolibrary.org/obo/MONDO_0011671>
p: direct-normalized/P699
<http://purl.obolibrary.org/obo/DOID_DOID:0090104>
wdt: P11430
"DI-01756"
wdt: P1193
0.000001^^xsd:decimal
wdt: P14914
"D98934"
wdt: P1550
"98934"
wdt: P1995
neurology
wdt: P2293
JPH3
wdt: P279
neuroacanthocytosis
wdt: P2841
adult onset
wdt: P2888
<http://identifiers.org/doid/DOID:0090104>
<http://purl.obolibrary.org/obo/DOID_0090104>
wdt: P2892
"C1847987"
wdt: P31
type of disease
rare disease
wdt: P4229
"G10"
wdt: P486
"C564708"
wdt: P492
"606438"
wdt: P5008
WikiProject Medicine
wdt: P5270
"MONDO_0011671"
wdt: P6532
choreatic disease
involuntary movement
Abnormal corpus striatum morphology
parkinsonian syndrome
movement disorders
Subcortical dementia
functional motor deficit
behavioral abnormality
memory disorder
abnormal reflex
personality change
weight loss
gait abnormality
dementia
dystonia
wdt: P699
"DOID:0090104"